Recent Company News

• 12:59 AM ET Apr 13, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (46 total)

• 12:54 AM ET Apr 08, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (20 total)

• 12:59 AM ET Apr 07, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (37 total)

• 12:05 AM ET Apr 02, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (29 total)

• 09:20 PM ET Apr 01, 2026
  

  Clinuvel Pharmaceuticals presents patient case studies from CUV105 study of afamelanotide for vitiligo at AAD 2026 (A$9.25, -0.49)

• 07:42 PM ET Feb 26, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 12:01 AM ET Mar 19, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (85 total)

• 03:52 AM ET Feb 26, 2026
  

  Transcript Intelligence: Clinuvel Pharmaceuticals Q2 Earnings Guidance